These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 30122578
1. Assessment of oxytocin level, glucose metabolism components and cutoff values for oxytocin and anti-mullerian hormone in infertile PCOS women. Jahromi BN, Dabbaghmanesh MH, Bakhshaie P, Parsanezhad ME, Anvar Z, Alborzi M, Zarei A, Bakhshaei M. Taiwan J Obstet Gynecol; 2018 Aug; 57(4):555-559. PubMed ID: 30122578 [Abstract] [Full Text] [Related]
2. Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome. Yetim Şahin A, Baş F, Yetim Ç, Uçar A, Poyrazoğlu Ş, Bundak R, Darendeliler F. Turk J Med Sci; 2019 Aug 08; 49(4):1117-1125. PubMed ID: 31286756 [Abstract] [Full Text] [Related]
3. Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS. Caglar GS, Kahyaoglu I, Pabuccu R, Demirtas S, Seker R. Arch Gynecol Obstet; 2013 Oct 08; 288(4):905-10. PubMed ID: 23553200 [Abstract] [Full Text] [Related]
4. Serum AMH levels and insulin resistance in women with PCOS. Sahmay S, Aydogan Mathyk B, Sofiyeva N, Atakul N, Azemi A, Erel T. Eur J Obstet Gynecol Reprod Biol; 2018 May 08; 224():159-164. PubMed ID: 29605710 [Abstract] [Full Text] [Related]
13. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes. Sova H, Unkila-Kallio L, Tiitinen A, Hippeläinen M, Perheentupa A, Tinkanen H, Puukka K, Bloigu R, Piltonen T, Tapanainen JS, Morin-Papunen L. Gynecol Endocrinol; 2019 Jul 08; 35(7):595-600. PubMed ID: 30668196 [Abstract] [Full Text] [Related]
14. Anti-Müllerian Hormone Accelerates Pathological Process of Insulin Resistance in Polycystic Ovary Syndrome Patients. Li XJ, Wang H, Lu DY, Yu TT, Ullah K, Shi XY, Shen YH, Fei XY, Lin ZY, Huang HF, Lin XH. Horm Metab Res; 2021 Aug 08; 53(8):504-511. PubMed ID: 34384107 [Abstract] [Full Text] [Related]
15. Comparison of serum anti-Müllerian hormone levels in normal weight and overweight-obese adolescent patients with polycystic ovary syndrome. Cengiz H, Ekin M, Dagdeviren H, Yildiz Ş, Kaya C, Kanawati A. Eur J Obstet Gynecol Reprod Biol; 2014 Sep 08; 180():46-50. PubMed ID: 25036408 [Abstract] [Full Text] [Related]
16. Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS). Park HT, Cho GJ, Ahn KH, Shin JH, Kim YT, Hur JY, Kim SH, Lee KW, Kim T. Clin Endocrinol (Oxf); 2010 Jan 08; 72(1):26-31. PubMed ID: 19438903 [Abstract] [Full Text] [Related]
18. Serum anti-Müllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China. Tian X, Ruan X, Mueck AO, Wallwiener D, Wang J, Liu S, Yin D, Lu Y, Zhang Y, Wu H. Gynecol Endocrinol; 2014 Nov 08; 30(11):836-9. PubMed ID: 25045796 [Abstract] [Full Text] [Related]
19. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Chen MJ, Yang WS, Chen CL, Wu MY, Yang YS, Ho HN. Hum Reprod; 2008 Apr 08; 23(4):952-7. PubMed ID: 18256110 [Abstract] [Full Text] [Related]
20. Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome. Tokmak A, Kokanali D, Timur H, Kuntay Kokanali M, Yilmaz N. Gynecol Endocrinol; 2016 Nov 08; 32(11):926-930. PubMed ID: 27275748 [Abstract] [Full Text] [Related] Page: [Next] [New Search]